The cancer patient and quality of life

被引:224
作者
Bottomley, A [1 ]
机构
[1] EORTC Data Ctr, European Org Res & Treatment Canc, B-1200 Brussels, Belgium
关键词
health-related quality of life; rHuEpo; fatigue; subjective experience; cancer;
D O I
10.1634/theoncologist.7-2-120
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over the last decade, clinicians have accepted that while survival and disease-free survival are critical factors for cancer patients, overall quality-of-life is fundamental. This review considers recent developments in the field of quality of life, oncological challenges and future directions.
引用
收藏
页码:120 / 125
页数:6
相关论文
共 57 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] ABELS RI, 1998, JPMA J PAK MED ASS, V48, P127
  • [3] Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomized trial with quality of life as the primary outcome
    Anderson, H.
    Hopwood, P.
    Stephens, R. J.
    Thatcher, N.
    Cottier, B.
    Nicholson, M.
    Milroy, R.
    Maughan, T. S.
    Falk, S. J.
    Bond, M. G.
    Burt, P. A.
    Connolly, C. K.
    McIllmurray, M. B.
    Carmichael, J.
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 447 - 453
  • [4] Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment:: Does quality of life matter?
    Bernhard, J
    Thürlimann, B
    Schmitz, SFH
    Castiglione-Gertsch, M
    Cavalli, F
    Morant, R
    Fey, MF
    Bonnefoi, H
    Goldhirsch, A
    Hürny, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1672 - 1679
  • [5] Oncologists' use of quality of life information: Results of a survey of Eastern Cooperative Oncology Group physicians
    Bezjak, A
    Ng, P
    Skeel, R
    DePetrillo, AD
    Comis, R
    Taylor, KM
    [J]. QUALITY OF LIFE RESEARCH, 2001, 10 (01) : 1 - 13
  • [6] Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer
    Bishop, JF
    Dewar, J
    Toner, GC
    Smith, J
    Tattersall, MHN
    Olver, IN
    Ackland, S
    Kennedy, I
    Goldstein, D
    Gurney, H
    Walpole, E
    Levi, J
    Stephenson, J
    Canetta, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2355 - 2364
  • [7] QUALITY OF LIFE IN CANCER-PATIENTS - AN HYPOTHESIS
    CALMAN, KC
    [J]. JOURNAL OF MEDICAL ETHICS, 1984, 10 (03) : 124 - 127
  • [8] Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer
    Cardenal, F
    López-Cabrerizo, MP
    Antón, A
    Alberola, V
    Massuti, B
    Carrato, A
    Barneto, I
    Lomas, M
    García, M
    Lianes, P
    Montalar, J
    Vadell, C
    González-Larriba, JL
    Nguyen, B
    Artal, A
    Rosell, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 12 - 18
  • [9] IMPROVING THE QUALITY-OF-LIFE DURING CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A COMPARISON OF INTERMITTENT AND CONTINUOUS TREATMENT STRATEGIES
    COATES, A
    GEBSKI, V
    BISHOP, JF
    JEAL, PN
    WOODS, RL
    SNYDER, R
    TATTERSALL, MHN
    BYRNE, M
    HARVEY, V
    GILL, G
    SIMPSON, J
    DRUMMOND, R
    BROWNE, J
    VANCOOTEN, R
    FORBES, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (24) : 1490 - 1495
  • [10] Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
    Demetri, GD
    Kris, M
    Wade, J
    Degos, L
    Cella, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3412 - 3425